Hemispherx Biopharma (NYSE: HEB) announces that the European subsidiary, “Hemispherx Biopharma Europe N.V./S.A.” gained a positive opinion from the COMP ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE